Pentoxifylline (PTX) is a medicine used since 1984 for leg blood vessel problems. Now, it's being studied to see if it helps protect kidneys in people with diabetic kidney disease (DKD), a condition where kidneys are damaged due to diabetes. In the U.S., DKD is a leading cause of chronic kidney disease and end-stage renal disease (ESRD)
- The study requires only 2 in-person visits, with other contacts done by phone.
- Participants must have type-2 diabetes and fit certain kidney function criteria.
- The study could help reduce the need for costly kidney treatments like dialysis.
To join, you must be a U.S. Veteran receiving care at a participating VA hospital and meet specific health criteria. Some exclusions apply, like type-1 diabetes or recent organ transplants. If successful, PTX could lessen the burden of kidney disease on Veterans.